IP Library Granted Patent US 6,881,556
Granted Patent B2
US 6,881,556 · App. 10/225,073 · Granted Apr 19, 2005

Polynucleotide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,881,556
App. No.
10/225,073
Granted
Apr 19, 2005
Kind
B2
Abstract

The present invention relates to a polynucleotide comprising a ubiquitous chromatin opening element (UCOE) which is not derived from 13. The polynucleotide of any one of claims 1 to 7 , wherein the UCOE comprises the sequence of FIG. 20 between nucleotides 1 to 7627 or a functional homologue or fragment thereof. an LCR. The present invention also relates to a vector comprising the polynucleotide sequence, a host cell comprising the vector, use of the polynucleotide, vector or host cell in therapy and in an assay, and a method of identifying UCOEs. The UCOE opens chromatin or maintains chromatin in an open state and facilitates reproducible expression of an operably-linked gene in cells of at least two different tissue types.

Claims (45)

1. A method for obtaining a desired gene product comprising culturing a host cell comprising a vector comprising a polynucleotide comprising:

a. an element comprising an extended methylation-free CpG-island;

b. an expressible gene, wherein said expressible gene is operably-linked to said CpG-island; and

c. a promoter, operably-linked to said gene, wherein said promoter is not naturally operably-linked to said CpG-island,

wherein said element facilitates reproducible activation of transcription of said gene in two or more tissue types.

2. A method for obtaining a desired gene product comprising culturing a host cell comprising a vector comprising a polynucleotide comprising:

a. an element comprising an extended methylation-free CpG-island comprising at least one endogenous promoter;

b. an expressible gene, wherein said expressible gene is operably-linked to said CpG-island, further wherein said expressible gene is not naturally linked to said CpG-island; and

c. a further promoter, external to said CpG-island, operably-linked to said gene, wherein said further promoter is not naturally operably-linked to said CpG-island,

wherein said element facilitates reproducible activation of transcription of said gene in two or more tissue types.

3. A method for obtaining a desired gene product comprising culturing a host cell comprising a vector comprising a polynucleotide comprising:

a. an element comprising an extended methylation-free CpG-island comprising at least one endogenous promoter;

b. an expressible gene, wherein said expressible gene is operably-linked to said CpG-island, further wherein said expressible gene is not naturally linked to said CpG-island; and

c. a further promoter, external to said CpG-island, operably-linked to said gene,

wherein said further promoter is not naturally operably-linked to said CpG-island, wherein said element facilitates reproducible activation of transcription of said gene.

4. A method for reproducibly expressing a gene comprising operably-linked said gene to a polynucleotide comprising:

a. an element comprising an extended methylation-free CpG-island;

b. an expressible gene, wherein said expressible gene is operably-linked to said CpG-island; and

c. a promoter, operably-linked to said gene, wherein said promoter is not naturally operably-linked to said CpG-island,

wherein said element facilitates reproducible activation of transcription of said gene in two or more tissue types.

5. A method for reproducibly expressing a gene comprising operably-linked said gene to said polynucleotide comprising:

a. an element comprising an extended methylation-free CpG-island comprising at least one endugenous promoter;

b. an expressible gene, wherein said expressible gene is operably-linked to said CpG-island, further wherein said expressible gene is not naturally linked to said CpG-island; and

c. a further promoter, external to said CpG-island, operably-linked to said gene, wherein said further promoter is not naturally operably-linked to said CpG-island,

wherein said element facilitates reproducible activation of transcription of said gene in two or more tissue types.

6. A method for reproducibly expressing a gene comprising operably-linked said gene to a polynucleotide comprising:

a. an element comprising an extended methylation-free CpG-island comprising at least one endogenous promoter;

b. an expressible gene, wherein said expressible gene is operably-linked to said CpG-island, further wherein said expressible gene is not naturally linked to said CpG-island; and

c. a further promoter, external to said CpG-island, operably-linked to said gene,

wherein said further promoter is not naturally operably-linked to said CpG-island, wherein said element facilitates reproducible activation of transcription of said gene.

7. A method for preparing a vector for reproducibly expressing a gene comprising operably-linked a polynucleotide comprising:

a. an element comprising an extended methylation-free CpG-island;

b. an expressible gene, wherein said expressible gene is operably-linked to said CpG-island; and

c. a promoter, operably-linked to said gene, wherein said promoter is not naturally operably-linked to said CpG-island,

wherein said element facilitates reproducible activation of transcription of said gene in two or more tissue types.

8. A method for preparing a vector for reproducibly expressing a gene comprising operably-linked a polynucleotide comprising:

a. an element comprising an extended methylation-free CpG-island comprising at least one endogenous promoter;

b. an expressible gene, wherein said expressible gene is operably-linked to said CpG-island, further wherein said expressible gene is not naturally linked to said CpG-island; and

c. a further promoter, external to said CpG-island, operably-linked to said gene, wherein said further promoter is not naturally operably-linked to said CpG-island,

wherein said element facilitates reproducible activation of transcription of said gene in two or more tissue types.

9. A method for preparing a vector for reproducibly expressing a gene comprising operably-linked to a polynucleotide comprising:

a. an element comprising an extended methylation-free CpG-island comprising at least one endogenous promoter;

b. an expressible gene, wherein said expressible gene is operably-linked to said CpG-island, further wherein said expressible gene is not naturally linked to said CpG-island; and

c. a further promoter, external to said CpG-island, operably-linked to said gene,

wherein said further promoter is not naturally operably-linked to said CpG-island, wherein said element facilitates reproducible activation of transcription of said gene.

Assignments (6)
CHANGE OF ADDRESS Recorded Feb 15, 2018
From: EMD MILLIPORE CORPORATION
To: EMD MILLIPORE CORPORATION
Reel/Frame 045341/0166 →
CHANGE OF NAME Recorded Jan 31, 2012
From: MILLIPORE CORPORATION
To: EMD MILLIPORE CORPORATION
Reel/Frame 027620/0891 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ALL OF IT - CLIENT WISHES TO RECORD EACH MERGER SEPARATELY. PREVIOUSLY RECORDED ON REEL 019220 FRAME 0355. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER FROM SEROLOGICALS INVESTMENT COMPANY TO FINAL OWNER MILLIPORE CORPORATION.. Recorded Apr 8, 2008
From: SEROLOGICALS INVESTMENT COMPANY
To: SEROLOGICALS ROYALTY COMPANY
Reel/Frame 020762/0580 →
MERGER Recorded Apr 8, 2008
From: SEROLOGICALS FINANCE COMPANY
To: SEROLOGICALS CORPORATION
Reel/Frame 020762/0587 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ALL PATENTS LISTED PREVIOUSLY RECORDED ON REEL 019220 FRAME 0389. ASSIGNOR(S) HEREBY CONFIRMS THE SEROLOGICALS ROYALTY COMPANY MERGER THROUGH TO MILLIPORE CORPORATION. Recorded Apr 8, 2008
From: SEROLOGICALS ROYALTY COMPANY
To: SEROLOGICALS FINANCE COMPANY
Reel/Frame 020762/0592 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ALL PATENTS LISTED PREVIOUSLY RECORDED ON REEL 019220 FRAME 0389. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER FROM SEROLOGICALS ROYALTY COMPANY THROUGH TO MILLIPORE CORPORATION. Recorded Apr 8, 2008
From: SEROLOGICALS CORPORATION
To: MILLIPORE CORPORATION
Reel/Frame 020762/0599 →